UK Business Secretary Alok Sharma recently announced a global licensing deal had been signed between Oxford University and the pharma giant AstraZeneca. In a plan to vaccinate half the UK population, AstraZeneca will make 30 million doses of the Oxford Coronavirus vaccine by September.
The firm will make 100 million doses of the vaccine over time if it proves to prevent the infection. This will mean the UK will be the first country to get access to the Oxford vaccine, should it be successful.
This week, Oxford finished the first phase of human trials and issuing vaccine doses on schedule.